Translational studies of head and neck cancer in South America and Europe

• Grant number: 20/08805-1
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• Start date: August 01, 2020
• End date: March 31, 2022
• Field of knowledge: Health Sciences - Collective Health - Epidemiology
• Agreement: European Commission (Horizon 2020)
• Principal Investigator: Maria Paula Curado
• Grantee: Aline Borburema Neves
• Host Institution: A C Camargo Cancer Center. Fundação Antonio Prudente (FAP). São Paulo , SP, Brazil
• Associated research grant: 18/26297-3 - Translational studies of head and neck cancer in South America and Europe, AP.TEM

Abstract

Worldwide, more than 550,000 new cases of head and neck cancer (HNC) occur each year, resulting inapproximately 300,000 deaths annually. It is the 6th most common cancer in both Europe and South America. Amajor reason for the high mortality rate for this cancer is the late stage of diagnosis for many patients. Accurateassessment of the prognosis of HNC cases also allows for appropriate treatment decisions. HEADSpAcE will bringtogether a consortium of 15 partners with a long and successful record of collaboration in HNC. The impact ofHEADSpAcE will be to understand reasons for late diagnosis and reduce the proportion of HNC that are diagnosedat a very late stage. It will identify the most appropriate way to diagnosis cancer caused by human papillomavirus (HPV), and also provide genomic evidence of strong predictors of prognosis that will have the potential toimprove care and reduce treatment related morbidity. Within this project we will develop guidelines forimplementation into clinical care. All these activities will be disseminated through communications tools achievingresearchers, young researchers and pos graduate students, for patient and family will be available throughHEADSpAce website. (AU)